Article Details

Vor Biopharmas CEO on Genome Engineering of Hematopoietic Stem Cells - Clinical Leader

Retrieved on: 2021-12-28 13:14:17

Tags for this article:

Click the tags to see associated articles and topics

Vor Biopharmas CEO on Genome Engineering of Hematopoietic Stem Cells - Clinical Leader. View article details on hiswai:

Excerpt

Vor Biopharma's CEO Dr. Robert Ang explains the company's lead engineered hematopoietic cell (eHSC) product candidate, genome engineering of...

Article found on: www.clinicalleader.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up